Cargando…
Inhibiting TRF1 upstream signaling pathways to target telomeres in cancer cells
In the context of tumorigenesis, telomere shortening is associated with apparent antagonistic outcomes: On one side, it favors cancer initiation through mechanisms involving genome instability, while on the other side, it prevents cancer progression, due to the activation of the DNA damage response...
Autores principales: | Cherfils‐Vicini, Julien, Gilson, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609909/ https://www.ncbi.nlm.nih.gov/pubmed/31273935 http://dx.doi.org/10.15252/emmm.201910845 |
Ejemplares similares
-
A novel pathway links telomeres to NK-cell activity: Implications for immunotherapy
por: Cherfils-Vicini, Julien, et al.
Publicado: (2014) -
A Novel Screen for Expression Regulators of the Telomeric Protein TRF2 Identified Small Molecules That Impair TRF2 Dependent Immunosuppression and Tumor Growth
por: El Maï, Mounir, et al.
Publicado: (2021) -
TRF1 and TRF2 binding to telomeres is modulated by nucleosomal organization
por: Galati, Alessandra, et al.
Publicado: (2015) -
ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2
por: Picco, Vincent, et al.
Publicado: (2016) -
The N-terminal domains of TRF1 and TRF2 regulate their ability to condense telomeric DNA
por: Poulet, Anaïs, et al.
Publicado: (2012)